?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
187 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
187 Unternehmen gefunden • Seite 1 von 8
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Eli Lilly and Company | 95.4 | Arzneimittel (Pharmazeutisch) | USA | 994.9 Mrd. USD | 37.25 | 49.61 | 12.49 | 29.37 | ▲ 21.58% | ▲ 27.22% | 0.62% | ▲ 15.27% | 11 Jahre | 31.67% | ▲ 2.55% | 45.56% | ▲ 4.36% | 13.77% | ▼ -2.57% | 7 / 9 | 3,81 | 23-fach | 49 / 100 | 3,4 / 100 | −1,92 |
 | Johnson & Johnson | 86.3 | Arzneimittel (Pharmazeutisch) | USA | 640.0 Mrd. USD | 30.42 | 34.21 | 6.54 | 7.53 | ▲ 2.67% | ▲ 12.74% | 2.02% | ▲ 4.80% | 41 Jahre | 28.46% | ▼ -0.27% | 27.17% | ▼ -0.02% | 20.91% | ▼ -0.75% | 5 / 9 | 4,67 | 23-fach | 34 / 100 | 1,1 / 100 | −2,52 |
 | Zoetis Inc | 85.3 | Arzneimittel (Pharmazeutisch) | USA | 30.1 Mrd. USD | 11.53 | 12.74 | 3.17 | 9.58 | ▲ 7.24% | ▲ 10.29% | 2.91% | ▲ 16.22% | 12 Jahre | 28.23% | ▲ 0.48% | 38.00% | ▲ 0.43% | 24.12% | ▲ 1.20% | 8 / 9 | 6,67 | 14-fach | 43 / 100 | −1,5 / 100 | −2,48 |
 | Vertex Pharmaceuticals Inc | 83.8 | Arzneimittel (Biotechnologie) | USA | 130.6 Mrd. USD | 29.66 | 34.42 | 10.35 | 6.45 | ▲ 14.24% | ▲ 7.83% | - | - | - | 32.74% | ▼ -3.84% | 39.43% | ▼ -4.50% | 26.45% | ▼ -6.18% | 7 / 9 | 7,35 | > 50-fach | 39 / 100 | 1,2 / 100 | −2,16 |
 | Merck & Company Inc | 81.6 | Arzneimittel (Pharmazeutisch) | USA | 355.1 Mrd. USD | 111.91 | 22.11 | 5.35 | 8.47 | ▲ 9.35% | ▲ 20.90% | 2.36% | ▲ 5.51% | 15 Jahre | 28.12% | ▲ 0.48% | 36.17% | ▲ 1.88% | 19.04% | ▲ 0.18% | 4 / 9 | 4,23 | 12-fach | 34 / 100 | 1,3 / 100 | −2,24 |
 | United Therapeutics Corporation | 80.5 | Arzneimittel (Biotechnologie) | USA | 21.3 Mrd. USD | 16.26 | 19.51 | 6.76 | 3.33 | ▲ 16.50% | ▲ 20.99% | - | - | - | 41.94% | ▲ 3.14% | 47.67% | ▲ 2.66% | 32.70% | ▲ 1.20% | 8 / 9 | 17,14 | 38-fach | 36 / 100 | −2,9 / 100 | −2,27 |
 | Incyte Corporation | 80.2 | Arzneimittel (Biotechnologie) | USA | 24.6 Mrd. USD | 15.27 | 12.82 | 4.23 | 3.88 | ▲ 14.03% | - | - | - | - | 25.03% | ▼ -2.27% | 26.12% | ▼ -0.20% | 26.35% | ▼ -0.58% | 9 / 9 | 8,02 | > 50-fach | 68 / 100 | −1,8 / 100 | −2,42 |
 | Neurocrine Biosciences Inc | 80.0 | Arzneimittel (Biotechnologie) | USA | 15.9 Mrd. USD | 22.51 | 18.35 | 4.71 | 4.30 | ▲ 22.29% | ▲ 3.28% | - | - | - | 16.73% | ▲ 2.18% | 21.64% | ▲ 3.27% | 26.17% | ▲ 1.32% | 7 / 9 | 6,34 | 13-fach | 61 / 100 | −6,6 / 100 | −2,58 |
 | Exelixis Inc | 78.8 | Arzneimittel (Biotechnologie) | USA | 13.9 Mrd. USD | 16.16 | 11.82 | 5.71 | 7.54 | ▲ 18.63% | ▲ 47.58% | - | - | - | 33.73% | ▲ 4.80% | 37.59% | ▲ 5.06% | 36.39% | ▲ 4.12% | 7 / 9 | 7,85 | unbegrenzt | 79 / 100 | −3,6 / 100 | −2,59 |
 | ACADIA Pharmaceuticals Inc | 77.8 | Arzneimittel (Biotechnologie) | USA | 4.8 Mrd. USD | 12.60 | 27.50 | 4.21 | 3.67 | ▲ 19.39% | - | - | - | - | 36.49% | ▲ 20.77% | 9.78% | ▲ 15.73% | 9.81% | ▲ 11.05% | 6 / 9 | 3,94 | unbegrenzt | 63 / 100 | 18,0 / 100 | −0,81 |
 | ADMA Biologics Inc | 75.4 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | 12.24 | 17.75 | 4.04 | 5.06 | ▲ 64.60% | - | - | - | - | 28.80% | ▲ 32.38% | 37.53% | ▲ 27.74% | 5.45% | ▲ 39.54% | 5 / 9 | 8,78 | 7-fach | 47 / 100 | 15,5 / 100 | −0,22 |
 | Gilead Sciences Inc | 75.4 | Arzneimittel (Biotechnologie) | USA | 178.2 Mrd. USD | - | 13.74 | 5.85 | 15.07 | ▲ 3.58% | ▲ 133.35% | 2.27% | ▲ 2.92% | 10 Jahre | 28.90% | ▼ -0.30% | 39.74% | ▼ -1.42% | 32.12% | ▼ -0.97% | 8 / 9 | 3,37 | 7-fach | 39 / 100 | −2,6 / 100 | −2,45 |
 | Amgen Inc | 71.9 | Arzneimittel (Biotechnologie) | USA | 204.0 Mrd. USD | 23.33 | 20.05 | 5.35 | 17.45 | ▲ 7.64% | ▲ 1.20% | 2.64% | ▲ 7.44% | 14 Jahre | 20.99% | ▼ -1.60% | 29.06% | ▼ -1.53% | 22.05% | ▼ -2.27% | 8 / 9 | 0,34 | 3-fach | 29 / 100 | −2,5 / 100 | −2,35 |
 | Gyre Therapeutics Inc. | 71.3 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | - | - | 5.98 | 5.47 | ▲ 40.96% | - | - | - | - | 4.31% | ▲ 241.44% | 9.86% | ▲ 230.80% | -0.15% | ▲ 229.34% | 5 / 9 | 7,94 | - | 86 / 100 | 3,1 / 100 | −6,33 |
 | Regeneron Pharmaceuticals Inc | 71.1 | Arzneimittel (Biotechnologie) | USA | 80.5 Mrd. USD | 18.59 | 22.85 | 5.18 | 2.54 | ▲ 11.04% | ▲ 5.10% | 0.48% | - | - | 31.41% | ▼ -4.22% | 24.95% | ▼ -7.76% | 28.45% | ▼ -3.49% | 5 / 9 | 9,49 | > 50-fach | 30 / 100 | −1,2 / 100 | −2,55 |
 | Veracyte Inc | 70.7 | Arzneimittel (Biotechnologie) | USA | 3.3 Mrd. USD | 28.70 | 19.86 | 5.85 | 2.37 | ▲ 34.50% | - | - | - | - | 12.83% | ▲ 11.23% | 14.34% | ▲ 12.08% | 24.49% | ▲ 9.73% | 7 / 9 | 15,71 | > 50-fach | 26 / 100 | −5,0 / 100 | −2,61 |
 | Harmony Biosciences Holdings | 70.4 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | 13.34 | 6.81 | 2.52 | 2.42 | ▲ 40.30% | - | - | - | - | 18.27% | ▼ -0.72% | 24.00% | ▼ -1.01% | 40.06% | ▲ 1.34% | 5 / 9 | 7,28 | 11-fach | 53 / 100 | −14,9 / 100 | −3,21 |
 | Oramed Pharmaceuticals Inc | 70.2 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 96.92 | 1.38 | ▼ -5.85% | - | 5.36% | - | - | 3202.50% | ▲ 848.95% | -754.40% | ▼ -92.18% | -553.90% | ▼ -17.34% | 5 / 9 | 10,43 | 8-fach | 0 / 100 | 31,7 / 100 | - |
 | TG Therapeutics Inc | 70.1 | Arzneimittel (Biotechnologie) | USA | 8.3 Mrd. USD | 18.68 | - | 10.32 | 13.66 | ▲ 426.73% | - | - | - | - | 72.56% | ▲ 1711.87% | 20.01% | ▲ 1820.03% | -4.05% | ▲ 1515.71% | 4 / 9 | 2,11 | 3-fach | 48 / 100 | 44,4 / 100 | 4,34 |
 | MiMedx Group Inc | 70.1 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | 106.93 | 16.44 | 1.88 | 3.09 | ▲ 11.02% | - | - | - | - | 11.60% | ▲ 5.51% | 15.26% | ▲ 5.87% | 17.43% | ▲ 6.53% | 8 / 9 | 8,14 | 18-fach | 101 / 100 | −7,4 / 100 | −2,71 |
 | Theravance Biopharma Inc | 69.0 | Arzneimittel (Pharmazeutisch) | USA | 0.9 Mrd. USD | 16.41 | 17.04 | 8.47 | 3.05 | ▲ 8.38% | - | - | - | - | 98.54% | ▼ -86.80% | -12.33% | ▲ 101.36% | 221.93% | ▲ 155.46% | 8 / 9 | 2,84 | 6-fach | 21 / 100 | −27,3 / 100 | −3,84 |
 | Rigel Pharmaceuticals Inc | 67.9 | Arzneimittel (Biotechnologie) | USA | 0.9 Mrd. USD | 2.74 | 11.12 | 3.19 | 2.07 | ▲ 22.06% | - | - | - | - | 124.72% | ▲ 33.19% | 42.63% | ▲ 16.17% | 25.71% | ▲ 12.34% | 7 / 9 | 0,36 | 6-fach | 53 / 100 | 56,7 / 100 | 1,58 |
 | Keros Therapeutics Inc | 67.7 | Arzneimittel (Biotechnologie) | USA | 0.2 Mrd. USD | - | - | 6.62 | 0.84 | ▲ 149.98% | - | - | - | - | 35.65% | ▼ -409.83% | 28.94% | ▼ -474.62% | 43.41% | ▼ -351.40% | 6 / 9 | 12,03 | - | 72 / 100 | −6,1 / 100 | 4,29 |
 | Halozyme Therapeutics Inc | 67.0 | Arzneimittel (Biotechnologie) | USA | 12.2 Mrd. USD | 29.42 | 15.09 | 7.31 | 84.76 | ▲ 39.16% | ▲ 19.68% | - | - | - | 22.69% | ▼ -12.32% | 58.45% | ▲ 0.62% | 46.15% | ▼ -3.16% | 6 / 9 | 3,07 | 26-fach | 43 / 100 | −13,3 / 100 | −2,51 |
 | Krystal Biotech Inc | 66.7 | Arzneimittel (Biotechnologie) | USA | 10.3 Mrd. USD | 42.54 | 39.84 | 23.32 | 7.56 | - | - | - | - | - | 52.64% | - | 41.45% | - | 48.55% | - | 6 / 9 | 16,76 | unbegrenzt | 27 / 100 | 0,3 / 100 | −2,26 |
USA